Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1997;17:1039-1044

This Article
Right arrow Full Text
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pihlajamäki, J.
Right arrow Articles by Laakso, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pihlajamäki, J.
Right arrow Articles by Laakso, M.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 1997;17:1039-1044.)
© 1997 American Heart Association, Inc.


Articles

Codon 54 Polymorphism of the Human Intestinal Fatty Acid Binding Protein 2 Gene Is Associated With Dyslipidemias But Not With Insulin Resistance in Patients With Familial Combined Hyperlipidemia

Jussi Pihlajamäki; Johanna Rissanen; Sami Heikkinen; Leena Karjalainen; ; Markku Laakso

From the Department of Medicine, University of Kuopio (Finland).

Correspondence to Markku Laakso, MD, Department of Medicine, University of Kuopio, 70210 Kuopio, Finland. E-mail markku.laakso{at}uku.fi

Abstract Familial combined hyperlipidemia (FCHL) is associated with variable expression of dyslipidemias and insulin resistance. In nondiabetic Pima Indians an A to G substitution in codon 54 of the fatty acid binding protein 2 (FABP2) gene has been shown to be associated with insulin resistance. We screened the entire coding region of this gene by single-strand conformation polymorphism analysis in 24 probands (17 men and 7 women; age, 63.0±7.4 years [mean±SD]; body mass index [BMI], 27.7±4.2 kg/m2) who had FCHL and in 40 healthy men from a random population sample of 82 men (age, 54.0±5.0 years; BMI, 26.3±3.2 kg/m2). Insulin resistance was assessed with the euglycemic clamp in 58 subjects from FCHL families (14 probands with FCHL and 44 first-degree relatives of probands: 38 men and 20 women; age, 51.5±12.6 years; BMI, 25.5±3.9 kg/m2). We found three nucleotide substitutions in the FABP2 gene: GCT to ACT (Ala->Thr) in codon 54, GTA to GTG in codon 118, and GCGCA to GCACA in the 3'-noncoding region. Frequencies of these variants did not differ between the patients and control subjects. The Ala to Thr substitution in codon 54 was associated with a high lipid oxidation rate (P=.011 after adjustment for sex and family relationship), high HDL triglycerides (P=.042), and high LDL triglycerides (P=.013) but not with insulin resistance in subjects from FCHL families. The FABP2 gene is unlikely to be a major gene for FCHL, but it might affect lipid metabolism in subjects with FCHL.


Key Words: fatty acid binding protein 2 • familial combined hyperlipidemia • insulin resistance




This article has been cited by other articles:


Home page
Am. J. Clin. Nutr.Home page
M. Gastaldi, S. Diziere, C. Defoort, H. Portugal, D. Lairon, M. Darmon, and R. Planells
Sex-specific association of fatty acid binding protein 2 and microsomal triacylglycerol transfer protein variants with response to dietary lipid changes in the 3-mo Medi-RIVAGE primary intervention study
Am. J. Clinical Nutrition, December 1, 2007; 86(6): 1633 - 1641.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
S. Morcillo, G. Rojo-Martinez, F. Cardona, M. de la Cruz Almaraz, M. de la Soledad Ruiz de Adana, I. Esteva, I. Cardona, and F. Soriguer
Effect of the interaction between the fatty acid binding protein 2 gene Ala54Thr polymorphism and dietary fatty acids on peripheral insulin sensitivity: a cross-sectional study
Am. J. Clinical Nutrition, October 1, 2007; 86(4): 1232 - 1237.
[Abstract] [Full Text] [PDF]


Home page
Diabetes and Vascular Disease ResearchHome page
E. Martinez-Lopez, B. Ruiz-Madrigal, I. Hernandez-Canaveral, and A. Panduro
Association of the T54 allele of the FABP2 gene with cardiovascular risk factors in obese Mexican subjects
Diabetes and Vascular Disease Research, September 1, 2007; 4(3): 235 - 236.
[Abstract] [PDF]


Home page
J. Lipid Res.Home page
S. Stan, M. Lambert, E. Delvin, G. Paradis, J. O'Loughlin, J. A. Hanley, and E. Levy
Intestinal fatty acid binding protein and microsomal triglyceride transfer protein polymorphisms in French-Canadian youth
J. Lipid Res., February 1, 2005; 46(2): 320 - 327.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
T. Ueno, J. Tremblay, J. Kunes, J. Zicha, Z. Dobesova, Z. Pausova, A. Y. Deng, Y.-L. Sun, H. J. Jacob, and P. Hamet
Rat model of familial combined hyperlipidemia as a result of comparative mapping
Physiol Genomics, March 12, 2004; 17(1): 38 - 47.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
C. Verseyden, S. Meijssen, H. van Dijk, H. Jansen, and M. C. Cabezas
Effects of atorvastatin on fasting and postprandial complement component 3 response in familial combined hyperlipidemia
J. Lipid Res., November 1, 2003; 44(11): 2100 - 2108.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
E. P. Weiss, M. D. Brown, A. R. Shuldiner, and J. M. Hagberg
Fatty acid binding protein-2 gene variants and insulin resistance: gene and gene-environment interaction effects
Physiol Genomics, September 3, 2002; 10(3): 145 - 157.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. Meijssen, H. van Dijk, C. Verseyden, D.W. Erkelens, and M. C. Cabezas
Delayed and Exaggerated Postprandial Complement Component 3 Response in Familial Combined Hyperlipidemia
Arterioscler Thromb Vasc Biol, May 1, 2002; 22(5): 811 - 816.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Levy, D. Menard, E. Delvin, S. Stan, G. Mitchell, M. Lambert, E. Ziv, J. C. Feoli-Fonseca, and E. Seidman
The Polymorphism at Codon 54 of the FABP2 Gene Increases Fat Absorption in Human Intestinal Explants
J. Biol. Chem., October 19, 2001; 276(43): 39679 - 39684.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
J. Pihlajamaki, M. Austin, K. Edwards, and M. Laakso
A Major Gene Effect on Fasting Insulin and Insulin Sensitivity in Familial Combined Hyperlipidemia
Diabetes, October 1, 2001; 50(10): 2396 - 2401.
[Abstract] [Full Text]


Home page
Diabetes CareHome page
J. R. Galluzzi, L. A. Cupples, J. B. Meigs, P. W.F. Wilson, E. J. Schaefer, and J. M. Ordovas
Association of the Ala54-thr Polymorphism in the Intestinal Fatty Acid-Binding Protein With 2-h Postchallenge Insulin Levels in the Framingham Offspring Study
Diabetes Care, July 1, 2001; 24(7): 1161 - 1166.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
J. J Agren, H. M Vidgren, R. S Valve, M. Laakso, and M. I Uusitupa
Postprandial responses of individual fatty acids in subjects homozygous for the threonine- or alanine-encoding allele in codon 54 of the intestinal fatty acid binding protein 2 gene
Am. J. Clinical Nutrition, January 1, 2001; 73(1): 31 - 35.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
R. E. Pratley, L. Baier, D. A. Pan, A. D. Salbe, L. Storlien, E. Ravussin, and C. Bogardus
Effects of an Ala54Thr polymorphism in the intestinal fatty acid-binding protein on responses to dietary fat in humans
J. Lipid Res., December 1, 2000; 41(12): 2002 - 2008.
[Abstract] [Full Text]


Home page
FASEB J.Home page
G. VASSILEVA, L. HUWYLER, K. POIRIER, L. B. AGELLON, and M. J. TOTH
The intestinal fatty acid binding protein is not essential for dietary fat absorption in mice
FASEB J, October 1, 2000; 14(13): 2040 - 2046.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Georgopoulos, O. Aras, and M. Y. Tsai
Codon-54 Polymorphism of the Fatty Acid-Binding Protein 2 Gene Is Associated with Elevation of Fasting and Postprandial Triglyceride in Type 2 Diabetes
J. Clin. Endocrinol. Metab., September 1, 2000; 85(9): 3155 - 3160.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. Pihlajamaki, L. Karjalainen, P. Karhapaa, I. Vauhkonen, and M. Laakso
Impaired Free Fatty Acid Suppression During Hyperinsulinemia Is a Characteristic Finding in Familial Combined Hyperlipidemia, but Insulin Resistance Is Observed Only in Hypertriglyceridemic Patients
Arterioscler Thromb Vasc Biol, January 1, 2000; 20(1): 164 - 170.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. J. Agren, R. Valve, H. Vidgren, M. Laakso, and M. Uusitupa
Postprandial Lipemic Response Is Modified by the Polymorphism at Codon 54 of the Fatty Acid–Binding Protein 2 Gene
Arterioscler Thromb Vasc Biol, October 1, 1998; 18(10): 1606 - 1610.
[Abstract] [Full Text] [PDF]